CORDIS
EU research results

CORDIS

English EN
Biomarker Research Alliance for Diagnosing Heart Disease in the Ageing European Population

Biomarker Research Alliance for Diagnosing Heart Disease in the Ageing European Population

Objective

The ageing of the European population represents a rapidly rising social and economic challenge. Especially cardiovascular morbidity increases with age, but unfortunately, elderly patients are often difficult to diagnose due to confounding factors, leading to uncertainties in clinical decision making with huge impact on patients’ outcomes. Hence, there is an unmet need for novel biomarkers for more accurate diagnosis, risk assessment, and clinical outcome prediction for both acute and chronic cardiovascular diseases in the elderly.
The BestAgeing consortium aims to improve this lack of diagnostic capabilities by developing and validating innovative omics-based biomarkers particularly for elderly patients – supporting healthy ageing in Europe. Our study design addresses the most frequent and severe cardiovascular diseases of elderly patients by incorporating the appropriate disease cohorts and biomaterials from European populations. We aim to develop new omics-assays to diagnose cardiovascular disease, estimate risk, and monitor the response to treatment in elderly. This is envisaged to enable a more stratified and economic delivery of medicine. We expect that BestAgeing will generate novel European medical technologies that can improve the efficacy and efficiency of our care for elderly patients, which will also impact on socioeconomic wealth in Europe.

Coordinator

Heidelberg University Medical School

Address

Im Neuenheimer Feld 672
69120 Heidelberg

Germany

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 730 400

Administrative Contact

Thorsten Brietz (Mr.)

Participants (20)

Sort alphabetically

Sort by EU Contribution

Expand all

HUMMINGBIRD DIAGNOSTICS GMBH

Germany

EU Contribution

€ 1 872 492

UNIVERSITAT DES SAARLANDES

Germany

EU Contribution

€ 453 600

TARTU ULIKOOL

Estonia

EU Contribution

€ 531 400

UNIVERSITA DEGLI STUDI DI PADOVA

Italy

EU Contribution

€ 288 000

METANOMICS GMBH

Germany

EU Contribution

€ 383 226,60

Uppsala University

Sweden

EU Contribution

€ 420 400

JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN

Germany

EU Contribution

€ 396 400

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

EU Contribution

€ 366 400

Academisch Medisch Centrum bij de Universiteit van Amsterdam

Netherlands

EU Contribution

€ 534 400

ACS BIOMARKER BV

Netherlands

EU Contribution

€ 1 391 200

Health in Code SL

Spain

EU Contribution

€ 295 200

SIEMENS AKTIENGESELLSCHAFT

Germany

EU Contribution

€ 683 576

UNIVERSITA CATTOLICA DEL SACRO CUORE

Italy

EU Contribution

€ 144 000

SERVICIO MADRILENO DE SALUD

Spain

EU Contribution

€ 140 400

MULTIPLICOM NV

Belgium

EU Contribution

€ 402 400

STATE INSTITUTION NATIONAL SCIENTIFIC CENTER INSTITUTE OF CARDIOLOGY NAMED AFTER ACADEMICIAN M. D. STRAZHESKO NATIONAL ACADEMY MEDICAL SCIENCES OF UKRAINE

Ukraine

EU Contribution

€ 156 000

ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON

Greece

EU Contribution

€ 162 000

AZIENDA COMPLESSO OSPEDALIERO SAN FILIPPO NERI*

Italy

EU Contribution

€ 154 500

METANOMICS HEALTH GMBH

Germany

EU Contribution

€ 400 373,40

SIEMENS HEALTHCARE GMBH

Germany

Project information

Grant agreement ID: 306031

Status

Closed project

  • Start date

    1 February 2013

  • End date

    31 January 2018

Funded under:

FP7-HEALTH

  • Overall budget:

    € 15 194 316

  • EU contribution

    € 10 906 368

Coordinated by:

Heidelberg University Medical School

Germany